Kidney transplant recipients may no longer have to choose between paying for their immunosuppressant medications or paying their bills thanks to new legislation passed by US Congress.
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 (H.R. 5534), passed in December 2020, will take effect on January 1st, 2023. This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant. Individuals under 65 years of age will have to pay a premium during their first year of coverage.
“Right now, too many patients and their families worry about whether they can afford the treatment they need to keep their transplanted kidney, today we took an important step towards alleviating that burden.”
Representative Ron Kind
The U.S. Department of Health & Human Services indicates that this legislation will lead to vast Medicare savings.
For more information on H.R. 5534, visit the Congress Website